Pharma and a few penny stocks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
THE GOAL IS TO STAY AND CLOSE ABOVE .01
IF YOU SUPPORT THIS COMPANY THEN THROW A FEW BUCKS AT IT WHILE IT IS RISING>
I liked that article. Lots of eyes here soon
I am pushing a bit for the home team today. LOL. Averaging way up to keep the momo going. TGIF friends LOL
Imagine being able to buy KALY products at CVS in the future
CVS NOW SELLING CBD OILS TOO. THIS IS THE FUTURE
https://kdvr.com/2019/03/22/cvs-begins-selling-products-infused-with-cbd-in-colorado-7-other-states/
I got in yesterday right after the news dropped. i trimmed some profits and still have a nice position here. almost went read but I bought it very low yesterday so still some green now for my remaining shares. Slowly rising again and as the news spreads I think we will see more interest
headed for .01 sooner than later. long into 2020 :)
Back to .0132 on the ask now. turning back up
panic sellers and profit takers controlled the morning. As well as people who looked to drop this. Now it is leveling off.
LOAD WALL REMOVED
The test results are on their website
LOL. Price drops on POSTIVE NEWS. HOLDING AND ADDING HERE
https://finance.yahoo.com/news/kaly-publishes-cannabis-extract-copd-123000620.html
Agree
Well I never sold my core LOL. :) Glad to be back and posting. Had a wonderful vacation and time away.
Agree. Looking forward to the ride. Nice entry
I think we will see good numbers. Bright future. I am going long
I agree sir.. And a bit of a sleeper to boot. A true penny stock at under 2 cents. Glad to be in with you all. Tomorrow could be epic
49 million volume is 8 times the average volume.. Anyone else think that the tutes might be in here too?
news due to hit on final report. this could be a cbd play as well as a cpod health play.. could be massive
I think the final report that is dropping tomorrow will trump all the BS. I think we have much higher to go. the speculation took it from .01 to .017 almost today alone
Some moron trying to sell 1 million on the ask 2 minutes before the close LOL!!! I miss the OTC stocks. See you all in the morning. The volume here was epic as was the pps pop. This will hit a lot of scanners and the news tomorrow could be life changing
LOL!!!!! SELLERS GOT BURNED AS STOCK BOUNCES RIGHT BACK UP!!!
See ya tomorrow
trees being shook for shares. do not let your shares be stolen for chump change. IMO. Holding on for the news tomorrow
THIS IS NOT A SELL ON NEWS LOL!!!
Flippers selling end of day. if that news drops and is big this will skyrocket.. Regrets will be had by the sellers LOL
once we eat through the 16s this should run.
the final report due our tomorrow. BOOMMMMMM
I agree. I think no one knows the news yet as it dropped around 1pm today... LOL..
NEWS FROM FEB 5
DALLAS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published a preview of the recently announced long-term, pilot study on the treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates with cannabis extracts derived from Kali-Extracts patented cannabis extraction process. The study adds to the Kali-Extracts in vitro genomics study, previously announced, to evaluate the impact of its pharmaceutical grade cannabis extracts in combination with other therapies on COPD patients. The World Health Organization estimates 65 million people worldwide are afflicted with moderate to severe COPD and GlobalData forecasts that the COPD treatment market will reach $14.1 billion by 2025.
The primate study was conducted by Professor Jeffry Osbourn, Ph.D., from the University of Kentucky and his Biomedical Science Research Group (BSRG). Professor Osbourn made the following statement in regard to the research: “We investigated the effects of a novel, new oral-delivered agent for the treatment of lung diseases like asthma, and inflammation of the lung airways, in research animals. [color=red]To our surprise, the new [Kali-Extracts] supplement increased lung capacity by 2 to 3 times and increased the rate of breathing, returning lung function to normal. These large increases in lung function would likely lead to improved oxygen levels in the blood and increased breathing ability in these animals. Future experiments are planned to more closely identify the mechanisms of this improved overall lung function leading to greatly improved life styles and greater participation in daily activities for these patients.”[/color]
A final report on the primate study is coming in March.
Kali-Extracts, Inc. (“KALY”) is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. Similarly, KALY its patented cannabis extraction technology to develop pharmaceutical products internally and through partnerships.
KALY has licensed its extraction process to Puration, Inc. (USOTC: PURA) (“PURA”) for the production of beverages. With over $1 million in trailing twelve-month sales, PURA’s sales of EVERx CBD Sports Water are growing. KALY is now working with PURA to formulate a 25 MG CBD formula for a new CBD infused water product. Together, PURA and KALY have signed over a $1 million agreement to produce CBD infused water for Generex Biotechnology, Inc. (OTCQB: GNBT). The GNBT product is expected to be on shelves soon. The PURA and KALY agreement with GNBT is part of a larger agreement to explore potential pharmaceutical partnerships.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
KALY Confirms Pharmaceutical Cannabis Extract Report On Recent Trials Scheduled For Tomorrow
Dallas, TX -- March 21, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company plans to publish its phase one research on the pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates. The primate study adds to the Kali-Extracts in vitro genomics study, previously announced, to evaluate the impact of its pharmaceutical grade cannabis extracts in combination with other therapies on COPD patients.
KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. In addition developing pharmaceutical products internally and through partnerships, KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
bid building now!!!!!
dip got clobbered and back up we go
Yes 2019 was the strike year. I am long into 2020. Let it build slowly..
I loaded this on the news. 300k shares strong. Ride or die LOL
.017 coming in hot soon
Good to be back.. Took and extended break and am glad to see a nice rise in PPS here. Pennies coming
THEY HAVE US PATENTS
https://www.kali-extracts.com/
Thanks. Nice to see some healthy profits and positive moves by the Hindu Hustlers. LOL. :)
Oh way higher than that. LOL
TY. never left. I knew we would see a penny or bette2 in 2019 onward